← Back to Analyst Consensus 
ADPT Buy
Adaptive Biotechnologies Corp
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 13, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 1, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 29, 2026 | Goldman Sachs | initiate | — → Buy | — | 54% |
| Sep 22, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 30, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 30, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 30, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 30, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jul 9, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 17, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 12, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 6, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| May 6, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 6, 2026 | Guggenheim | reiterate | Buy → Buy | — | 52% |
| May 6, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Feb 6, 2026 | JP Morgan | maintain | Overweight → Overweight | $21 | 54% |
| Feb 6, 2026 | BTIG | maintain | Buy → Buy | $22 | 52% |
| Jan 26, 2026 | Guggenheim | maintain | Buy → Buy | $21 | 52% |
| Nov 11, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $16 | 54% |
| Nov 6, 2025 | JP Morgan | maintain | Overweight → Overweight | $20 | 54% |
| Nov 6, 2025 | BTIG | maintain | Buy → Buy | $21 | 52% |
| Oct 22, 2025 | BTIG | maintain | Buy → Buy | $19 | 52% |
| Oct 15, 2025 | Piper Sandler | maintain | Overweight → Overweight | $20 | 54% |
| Oct 13, 2025 | JP Morgan | maintain | Overweight → Overweight | $17 | 54% |
| Sep 30, 2025 | Guggenheim | initiate | — → Buy | $20 | 52% |
| Aug 6, 2025 | JP Morgan | maintain | Overweight → Overweight | $14 | 54% |
| Aug 6, 2025 | TD Cowen | maintain | Buy → Buy | $15 | 54% |
| Aug 6, 2025 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jun 18, 2025 | Craig-Hallum | initiate | — → Buy | $15 | 54% |
| May 6, 2025 | Piper Sandler | maintain | Overweight → Overweight | $13 | 54% |
| May 5, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| May 2, 2025 | Goldman Sachs | maintain | Buy → Buy | $10 | 54% |
| Mar 21, 2025 | Goldman Sachs | upgrade | Neutral → Buy | $9 | 54% |
| Feb 20, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $11 | 54% |
| Feb 13, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $12 | 55% |
| Jan 28, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $7.5 | 54% |
| Dec 18, 2024 | BTIG | maintain | Buy → Buy | $9 | 52% |
| Nov 11, 2024 | Piper Sandler | maintain | Overweight → Overweight | $7 | 54% |
| Oct 2, 2024 | BTIG | maintain | Buy → Buy | $8 | 52% |
| Aug 2, 2024 | JP Morgan | maintain | Overweight → Overweight | $6 | 54% |
| May 8, 2024 | JP Morgan | maintain | Overweight → Overweight | $5 | 54% |
| Apr 4, 2024 | BTIG | maintain | Buy → Buy | $5 | 52% |
| Feb 16, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $5 | 54% |
| Feb 15, 2024 | JP Morgan | maintain | Overweight → Overweight | $8 | 54% |
| Nov 13, 2023 | Piper Sandler | maintain | Overweight → Overweight | $6 | 54% |
| Oct 24, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $10 | 54% |
| Oct 16, 2023 | Piper Sandler | maintain | Overweight → Overweight | $13 | 54% |
Price Target Trend
Jun 7, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days